
Shareholders Target GRAIL Inc. in Securities Fraud Class Action
Investors who purchased GRAIL, Inc. securities between May 13, 2025, and February 19, 2026, face a deadline of August 4, 2026, to join a pending class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging that the biotech company misled the market regarding the efficacy of its NHS-Galleri trial.























